We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

DHI:NYSED.R. Horton, Inc. Analysis

Data as of 2026-03-10 - not real-time

$147.69

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

D.R. Horton (DHI) is trading at $147.69, just above its identified support of $141.90 and well below the 20‑day SMA of $159.15, suggesting room for upside. The 14‑day RSI of 35.7 points to an oversold condition, while the MACD remains bearish with the line at –1.82 versus a signal at 0.21, indicating short‑term momentum pressure. Volatility is elevated at 30% over the past 30 days, and volume trends are decreasing, which could amplify price swings around the upcoming Q2 earnings release scheduled for April 21, 2026. Fundamentally, the stock carries a modest PE of 13.4, a dividend yield of 1.22% with a low 15% payout ratio, and a DCF‑derived fair value of roughly $110, implying the market is pricing in growth expectations despite a –9.5% revenue decline.
Valuation appears mixed: the current price exceeds the DCF estimate but aligns with analyst target median of $162, giving an estimated upside of about 8%. The company’s low beta (~0.54) suggests limited systematic risk, while the “Extreme Greed” sentiment on the fear‑greed index (79.25) reflects strong market optimism. Overall, DHI presents a fairly valued, dividend‑sustainable play with upside potential tempered by cyclical housing exposure and short‑term technical weakness.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Upcoming Q2 earnings release on April 21, 2026
  • Oversold RSI indicating potential bounce
  • Bearish MACD and decreasing volume

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Price below 20‑day SMA with bullish trend direction
  • Estimated upside of ~8% toward analyst targets
  • Sustainable dividend with low payout ratio

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Cyclical exposure to U.S. residential construction
  • Stable cash flow and strong market position
  • Moderate valuation metrics and low beta

Key Metrics & Analysis

Financial Health

Revenue Growth-9.50%
Profit Margin9.95%
P/E Ratio13.4
ROE13.48%
ROA7.83%
Debt/Equity22.87
P/B Ratio1.8
Op. Cash Flow$3.6B
Free Cash Flow$-546750016

Technical Analysis

TrendBullish
RSI35.7
Support$141.90
Resistance$169.17
MA 20$159.15
MA 50$154.59
MA 200$150.63
MACDBearish
VolumeDecreasing
Fear & Greed Index79.25

Valuation

Fair Value$109.92
Target Price$160.13
Upside/Downside8.43%
GradeFair
TypeBlend
Dividend Yield1.22%

Risk Assessment

Beta0.54
Volatility30.22%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.